LHCTX Mutual Fund (Lord Abbett Health Care Fund Class R5) is managed by Lord Abbett Family of Funds. LHCTX expense ratio is 0.78%, holding 64 positions across sectors including Health Care, Unknown, Other. Inception date: 2019-07-31.

LHCTX performance shows a YTD return of 4.71%. The 1-year return is 27.63% and the 5-year return is 5.89%. LHCTX dividend yield stands at 0.36%, paid annually.

LHCTX top holdings include Eli Lilly And Company (8.9%), Astrazeneca Plc Adr (4.7%), Gilead Sciences Inc (4.3%), JOHNSON AND JOHNSON (3.2%), Nektar Therapeutics (3.2%). View all LHCTX holdings, sector breakdown, or dividend history.

LHCTX can be compared against other funds using the overlap calculator or side-by-side comparison tool. LHCTX alternatives are available via the screener, along with tax-loss harvesting opportunities.